Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
DiaMedica Therapeutics Inc. (DMAC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Daves Julie VanOrsdel (SVP Clinical Development Oper.) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 54,000 options to buy
@ $2.73, valued at
$147.4k
|
|
| 06/02/2023 |
4
| Cundari Dominic R (Chief Commercial Officer) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 27,000 options to buy
@ $2.73, valued at
$73.7k
|
|
| 06/02/2023 |
4
| Gruis Kirsten L (Chief Medical Officer) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 67,000 options to buy
@ $2.73, valued at
$182.9k
|
|
| 06/02/2023 |
4
| Kellen Scott (CFO and Secretary) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 67,000 options to buy
@ $2.73, valued at
$182.9k
|
|
| 06/02/2023 |
4
| Pauls Dietrich John (President and CEO) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 181,000 options to buy
@ $2.73, valued at
$494.1k
|
|
| 06/02/2023 |
4
| Semba Charles Pauling (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 16,968 options to buy
@ $2.73, valued at
$46.3k
|
|
| 06/02/2023 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 22,355 options to buy
@ $2.73, valued at
$61k
|
|
| 06/02/2023 |
4
| Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 16,968 options to buy
@ $2.73, valued at
$46.3k
|
|
| 05/30/2023 |
4
| Kuntz Richard (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 32,320 options to buy
@ $2.81, valued at
$90.8k
|
|
| 03/06/2023 |
4
| Lewis Tanya (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 26,443 options to buy
@ $1.77, valued at
$46.8k
|
|
| 01/03/2023 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 35,130 shares
@ $1.53, valued at
$53.7k
|
|
| 01/03/2023 |
4
| Burroughs Amy L. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 17,156 shares
@ $1.53, valued at
$26.2k
|
|
| 01/03/2023 |
4
| Semba Charles Pauling (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 17,156 shares
@ $1.53, valued at
$26.2k
|
|
| 01/03/2023 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 55,555 shares
@ $1.53, valued at
$85k
|
|
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| Daves Julie VanOrsdel (SVP Clinical Development Oper.) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 140,000 options to buy
@ $1.47, valued at
$205.8k
|
|
| 07/21/2022 |
4
| Von Koch Thomas (10% Owner) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Bought 207,974 shares
@ $1.3266, valued at
$275.9k
|
|
| 06/02/2022 |
4
| Pauls Dietrich John (President and CEO) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 177,000 options to buy
@ $2.45, valued at
$433.7k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Burroughs Amy L. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 13,222 options to buy
@ $2.45, valued at
$32.4k
|
|
| 06/02/2022 |
4
| Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 13,222 options to buy
@ $2.45, valued at
$32.4k
|
|
| 06/02/2022 |
4
| Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 13,222 options to buy
@ $2.45, valued at
$32.4k
|
|
| 06/02/2022 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 18,510 options to buy
@ $2.45, valued at
$45.3k
|
|
| 06/02/2022 |
4
| Semba Charles Pauling (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 13,222 options to buy
@ $2.45, valued at
$32.4k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Gruis Kirsten L (Chief Medical Officer) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 160,000 options to buy
@ $3.88, valued at
$620.8k
|
|
| 01/03/2022 |
4
| Burroughs Amy L. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 11,182 shares
@ $3.58, valued at
$40k
|
|
| 01/03/2022 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.|
Txns:
| Granted 23,762 shares
@ $3.58, valued at
$85.1k
|
|
|
|
|